We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals

111 hedge funds and large institutions have $356M invested in Amphastar Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 34

0.52% less ownership

Funds ownership: 52.31%51.79% (-0.52%)

7% less funds holding

Funds holding: 119111 (-8)

25% less capital invested

Capital invested by funds: $474M → $356M (-$118M)

33% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 18

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $160K

Holders
111
Holders Change
-8
Holders Change %
-6.72%
% of All Funds
2.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
40
Reduced
34
Closed
18
Calls
Puts
$160K
Net Calls
-$160K
Net Calls Change
+$180K
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
76
Royal Bank of Canada
Ontario, Canada
$209K +$222K +12,782 +1,008%
OPERF
77
Oregon Public Employees Retirement Fund
Oregon
$205K
Public Employees Retirement Association of Colorado
78
Public Employees Retirement Association of Colorado
Colorado
$204K
SG Americas Securities
79
SG Americas Securities
New York
$202K +$115K +6,612 +94%
State of Tennessee, Department of Treasury
80
State of Tennessee, Department of Treasury
Tennessee
$183K
MLICM
81
Metropolitan Life Insurance Company (MetLife)
New York
$181K +$6.73K +387 +3%
MSA
82
Mason Street Advisors
Wisconsin
$177K
MERSOM
83
Municipal Employees' Retirement System of Michigan
Michigan
$157K
Russell Investments Group
84
Russell Investments Group
United Kingdom
$115K +$136K +7,800 New
TRSOTSOK
85
Teachers Retirement System of the State of Kentucky
Kentucky
$104K
AIM
86
Aigen Investment Management
New York
$47K +$32.4K +1,863 +147%
MWNA
87
Marshall Wace North America
New York
$47K +$55.1K +3,165 New
AIP
88
Ameritas Investment Partners
Nebraska
$46K
Zurich Cantonal Bank
89
Zurich Cantonal Bank
Switzerland
$36K
PNC Financial Services Group
90
PNC Financial Services Group
Pennsylvania
$30K -$12.2K -704 -26%
MOACM
91
Mutual of America Capital Management
New York
$22K +$4.85K +279 +23%
US Bancorp
92
US Bancorp
Minnesota
$17K -$4.12K -237 -17%
LIA
93
LS Investment Advisors
Michigan
$16K
WAP
94
Wealthcare Advisory Partners
Pennsylvania
$16K
Osaic Holdings
95
Osaic Holdings
Arizona
$16K +$18.7K +1,075 New
PFPT
96
Pinnacle Financial Partners (Tennessee)
Tennessee
$15K
GT
97
Glenmede Trust
Pennsylvania
$13K
SWA
98
Sutton Wealth Advisors
Florida
$7.24K
VCM
99
Versant Capital Management
Arizona
$6K +$8.06K +463 New
MAM
100
Meeder Asset Management
Ohio
$4K -$9.5K -546 -67%

AMPH Hedge Fund Activity: Q1 2020 in Review

111 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q1 2020, worth a combined $356M — down 25% from $474M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of AMPH and 12 opened new positions — a net loss of 6 holders — while 34 trimmed existing stakes and 40 added.

The largest buyer was Federated Hermes, adding an estimated $14.8M. The largest seller was Arrowstreet Capital, exiting entirely with an estimated $10.1M sold.

  • 111 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q1 2020, down from 119 in Q4 2019.
  • Funds reported $356M of Amphastar Pharmaceuticals stock for Q1 2020, down 25% quarter-over-quarter.
  • 12 funds opened new Amphastar Pharmaceuticals positions in Q1 2020 and 18 closed out, a net change of -6 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q1 2020 was Federated Hermes, an estimated $14.8M added.
  • The largest Amphastar Pharmaceuticals seller in Q1 2020 was Arrowstreet Capital, an estimated $10.1M sold.

Based on aggregated 13F filings for Q1 2020.